Literature DB >> 22810022

The Jurdham procedure: endocardial left ventricular lead insertion via a femoral transseptal sheath for cardiac resynchronization therapy pectoral device implantation.

Benjamin Elencwajg1, Néstor López Cabanillas, Eduardo Luis Cardinali, José Luis Barisani, Jorge Trainini, Avi Fischer, Seth Worley.   

Abstract

BACKGROUND: Endocardial stimulation of the left ventricle for cardiac resynchronization therapy is a growing field of investigation. Despite the excellent results and absence of significant complications demonstrated thus far in the literature, the lack of a simple, straightforward, and standard technique limits its widespread utilization.
OBJECTIVE: To assess the feasibility, safety, simplicity, and complications of a technique for inserting the left ventricle lead through a femoral transseptal sheath to the pectoral implant site, termed "the Jurdham procedure."
METHODS: We performed the Jurdham procedure in 10 patients (8 men; 60.5 ± 1.8 years) in whom a coronary sinus lead implant had failed. A snared 85-cm standard active fixation endocardial pacing lead was implanted on the left ventricle endocardium through a femoral transseptal sheath with subsequent mobilization of the proximal end of the lead to the prepectoral area via the snare.
RESULTS: Successful implant was achieved in all 10 patients without complications, with excellent acute and chronic pacing parameters. All patients remained on chronic oral anticoagulation therapy without thromboembolic or bleeding complications. No late complications have occurred. All patients have improved at least 1 New York Heart Association functional class and have remained clinically stable during the follow-up term.
CONCLUSION: The Jurdham procedure is a reliable, technically easy technique to achieve cardiac resynchronization therapy via the endocardial approach. In our initial experience, there has been an excellent clinical response without significant complications during short-term follow-up. Additional investigation is needed to define the precise indications and limitations of this procedure.
Copyright © 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22810022     DOI: 10.1016/j.hrthm.2012.07.010

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  5 in total

Review 1.  Targeting left ventricular lead placement to improve cardiac resynchronization therapy outcomes.

Authors:  Jeffrey Liu; Evan Adelstein; Samir Saba
Journal:  Curr Cardiol Rep       Date:  2013-08       Impact factor: 2.931

Review 2.  Recent advances in the optimization of cardiac resynchronization therapy.

Authors:  Satish Chandraprakasam; Gina G Mentzer
Journal:  Curr Heart Fail Rep       Date:  2015-02

3.  Wire Transfer from the Femoral to Axillary Vein to Implant a Coronary Sinus Lead.

Authors:  Serkan Cay; Ozcan Ozeke; Firat Ozcan; Dursun Aras; Serkan Topaloglu
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

4.  Developments in Cardiac Resynchronisation Therapy.

Authors:  Geoffrey F Lewis; Michael R Gold
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-08

Review 5.  Strategies to improve cardiac resynchronization therapy.

Authors:  Kevin Vernooy; Caroline J M van Deursen; Marc Strik; Frits W Prinzen
Journal:  Nat Rev Cardiol       Date:  2014-05-20       Impact factor: 32.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.